Product Information
CARBIDOPA-LEVODOPA 25-100 TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0732 per EA under NDC 31722038205. Its NADAC has been published 40 times since Sep 24, 2025.
Strength
25; 100 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722038205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA218939On Market Since
5/27/2025
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has been published 40 times since Sep 24, 2025, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0732 per EA |
|---|---|
| All-time high | $0.0818 (Oct 15, 2025) |
| All-time low | $0.0719 (May 20, 2026) |
| 52-week high | $0.0818 |
| 52-week low | $0.0719 |
| Median price | $0.0765 |
| Average price | $0.0766 |
| Largest weekly change | -3.5% (Jan 21, 2026) |
| Weeks tracked | 40 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-100 TAB, manufactured by Camber Pharmaceuticals Inc., is $0.0732 per EA (NDC 31722038205), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has declined 10.5%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-100 TAB?
Since Sep 24, 2025, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has ranged from a low of $0.0719 (May 20, 2026) to a high of $0.0818 (Oct 15, 2025), with a median of $0.0765 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-100 TAB?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 25-100 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-100 TAB?
CARBIDOPA-LEVODOPA 25-100 TAB (NDC 31722038205) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification